Tuesday 09 February, 2010This week

Drug disappoints in recurrent glioblastoma

05/02/2010 | Hopes for treating recurrent glioblastoma with enzastaurin - a targeted anti-angiogenic - have been dashed by disappointing phase III study results.

Long-term transplant outcomes similar in leukaemia

05/02/2010 | Patients transplanted with peripheral blood stem cells have no difference in survival compared with patients given bone marrow after 10 years, research shows.

Outlook for lung cancer patients remains grim

05/02/2010 | The prognosis for lung cancer patients remains poor, with most still diagnosed with advanced disease, a study from Western Australia shows.